Nasal spray, 0.68 fl oz

• Product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, at levels above specifications.
• Company: MediNatura New Mexico Inc.
• Drugs
• FDA
• December 10, 2025

Product details

• Nasal spray, 0.68 fl oz

Company announcement

MediNatura New Mexico, Inc. is voluntarily recalling ReBoost Nasal Spray due to microbial contamination.

The product was distributed nationwide.

The recall was initiated December 10, 2025. No adverse events have been reported.

Risk:

There is a reasonable probability that adverse health consequences including life-threatening infections will occur with use of the product in the immuno-compromised population.

Impacted states: Nationwide

Products:

- ReBoost Nasal Spray (UPC code(s): 787647101863)

Contact

For more information, call (800) 621-7644 or email recall@medinatura.com.

View the original FDA notice

Browse all recalls

Related recalls

• Argatroban Injection 250 mg/2.5 mL (100 mg/mL)
• Brevital Sodium 500 mg/vial for Injection
• Glutathione Injection
• Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) for Intravenous Infusion
• 0.9% Sodium Chloride Injection, USP, 100 mL
• Compounded Glutathione 200 mg/mL 30 mL multidose vial; Myer’s Cocktail 30 mL multidose vial; Tri-Immune Boost 30 mL multidose vial